Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings

Key Findings:  CBD was shown to be therapeutic in the treatment of certain pediatric seizure disorders; helpful in patients with Parkinson's disease (PD) (improvements in sleep and quality of life); potentially useful in the treatment of anxiety and psychosis (schizophrenia); anti-addictive in alcohol and drug addictions.

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Form of Administration:  Not Applicable

Study Location(s):  Canada

Year of Pub:  2019

Link to study